KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Minority Interest (2021 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Minority Interest for 6 consecutive years, with $127.0 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Minority Interest rose 7.63% year-over-year to $127.0 million, compared with a TTM value of $127.0 million through Sep 2024, up 7.63%, and an annual FY2023 reading of $118.0 million, up 1.72% over the prior year.
  • Minority Interest was $127.0 million for Q3 2024 at Thermo Fisher Scientific, up from $115.0 million in the prior quarter.
  • Across five years, Minority Interest topped out at $127.0 million in Q3 2024 and bottomed at $113.0 million in Q2 2022.
  • Average Minority Interest over 4 years is $118.3 million, with a median of $118.0 million recorded in 2023.
  • The sharpest move saw Minority Interest fell 4.92% in 2022, then grew 8.85% in 2023.
  • Year by year, Minority Interest stood at $122.0 million in 2021, then dropped by 4.92% to $116.0 million in 2022, then rose by 1.72% to $118.0 million in 2023, then grew by 7.63% to $127.0 million in 2024.
  • Business Quant data shows Minority Interest for TMO at $127.0 million in Q3 2024, $115.0 million in Q2 2024, and $119.0 million in Q1 2024.